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Abstract
Objectives—Serum lactate monitoring is central to risk stratification and management of sepsis 
and is now part of a potential quality measure. We examined 11-year trends in lactate testing and 
predictors of failure to measure lactates in patients with severe sepsis.
Design—Retrospective cohort study.
Setting—Two U.S. academic hospitals.
Patients—Adult patients admitted from 2003–2013.
Interventions—Annual rates of lactate measurement were assessed in patients who had blood 
cultures ordered and patients with severe sepsis, as defined by concomitant ICD-9 codes for 
infection and organ dysfunction. The approximate time of suspected sepsis was determined by the 
first blood culture order with concurrent antibiotic initiation. Multivariate analysis was performed 
to identify predictors of failure to measure lactates in severe sepsis cases in 2013.
Measurements and Results—Among hospitalizations with blood culture orders, rates of 
lactate measurement increased from 11% in 2003 to 48% in 2013 (p<0.001 for linear trend). Rates 
of repeat lactate measurement within 6 hours after lactate levels ≥ 4.0 mmol/L increased from 23% 
to 69% (p<0.001). Patients were progressively less likely to be on vasopressors at the time of first 
lactate measurement (49% in 2003 vs 21% in 2013, p<0.001). Despite these trends, lactates were 
measured at the time of suspected sepsis in only 65% of patients with severe sepsis in 2013. On 
multivariate analysis, hospital-onset of sepsis and hospitalization on a nonmedical service were 
Corresponding Author: Chanu Rhee MD (crhee1@partners.org), Department of Population Medicine, Harvard Medical School and 
Harvard Pilgrim Health Care Institute 133 Brookline Avenue, 6th Floor, Boston, MA 02215, Phone: 617-509-9987, Fax: 
617-859-8112.
Address for reprints: Same as above. Reprints will not be ordered.
Potential conflicts of interest.
None of the authors have any potential conflicts of interest to disclose.
Copyright form disclosures:
Dr. Rhee received support for article research from the National Institutes of Health (NIH). His institution received grant support from 
the CDC and the NIH (CDC Grant # 3U54CK00172- 04S1, NIH T32 AI007061). Dr. Platt’s institution received grant support from 
the Centers for Disease Control and Prevention. Dr. Klompas’ institution received grant support from the CDC. The remaining authors 
have disclosed that they do not have any potential conflicts of interest.
HHS Public Access
Author manuscript
Crit Care Med. Author manuscript; available in PMC 2016 August 01.
Published in final edited form as:
Crit Care Med. 2015 August ; 43(8): 1669–1676. doi:10.1097/CCM.0000000000001087.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
significant predictors of failure to measure lactates (adjusted ORs 7.56, 95% CI 6.31–9.06 and 
2.08, 95% CI 1.76–2.24, respectively).
Conclusions—Lactate testing has increased dramatically over time and is being extended to 
patients without overt shock. However, rates of serial lactate testing are still suboptimal and 
lactates are not being measured in many patients with severe sepsis. Hospital-onset sepsis and 
nonmedical units may be high-yield targets for quality improvement initiatives.
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INTRODUCTION
Elevated serum lactate levels have long been known to identify patients with severe 
hypoperfusion and predict death [1–3]. Measuring lactate levels have been shown to risk 
stratify patients with suspected sepsis, to prompt aggressive early treatment, and to help 
monitor the impact of therapy [4–9]. Implementation of bedside lactate measurement in the 
emergency department has also been associated with reduced time to administration of 
intravenous fluids in patients with suspected sepsis and decreased rates of ICU admission 
and mortality [10].
For these reasons, lactate testing in all patients with suspected severe sepsis has become 
increasingly emphasized and is now a key component of the Surviving Sepsis Campaign 
(SSC) Guidelines. In the most recent version of the guidelines, lactate measurement is a core 
component of the 3-hour bundle, while repeat lactate measurement for patients with 
hyperlactatemia is part of the 6-hour bundle [11]. The National Quality Forum’s adoption of 
the SSC guidelines means that lactate measurement in severe sepsis could be included in 
future quality measures for public reporting and payment [12].
Participation in the SSC has been shown to improve compliance with the severe sepsis 
bundle, including increasing the frequency of lactate measurement within the first 6 hours of 
meeting screening criteria [13, 14]. However, less is known about how lactate use has 
changed over time or how frequently clinicians are ordering this test in appropriate patients 
in hospitals that are not associated with the SSC. In addition, little is known about which 
clinical factors are associated with failure to measure a lactate in potentially septic patients. 
Given the benefits associated with lactate testing, it is important to better understand how 
this test is being utilized, and gaps in its use, in order to identify potential areas for quality 
improvement.
We evaluated 11-year trends in serum lactate testing in patients with suspected sepsis and 
identified predictors of failure to appropriately measure lactates using a detailed clinical 
database at two academic medical centers that were not participating sites in the SSC.
MATERIALS AND METHODS
After obtaining approval from the Partners Healthcare Institutional Review Board, we 
identified all patients aged 18 and older admitted to Massachusetts General Hospital (MGH) 
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and Brigham and Women’s Hospital (BWH) between January 1st, 2003 and December 31st, 
2013 who had a blood culture order during hospitalization. MGH (950 beds) and BWH (779 
beds) are academic hospitals located in Boston, Massachusetts. We retrieved comprehensive 
clinical data including patients’ demographics, International Classification of Diseases, 
Ninth Revision, Clinical Modification (ICD-9-CM) codes, medications, laboratory results, 
and dates of admission, discharge, and death from the hospital’s Research Patient Data 
Registry, a centralized clinical data warehouse [15]. Any serum lactate test, whether from an 
arterial or venous sample, was included in our analysis. Blood culture data was obtained 
from the clinical microbiology laboratory database and ventilator data was obtained from the 
Respiratory Therapy Departments of each hospital. Patients’ comorbidities were derived 
from their ICD-9-CM and diagnosis-related group codes using the method of Elixhauser and 
we used a validated summary scoring method to estimate total burden of comorbidities [16, 
17]. Patients who required intensive care unit (ICU) services were identified using the 
Current Procedural Terminology (CPT) code 99291 (critical care, first 30–74 mins). This 
approach for identifying critically ill patients has been previously validated in our 
administrative data source [18].
Patient Subgroups
We explored three different denominators to assess trends in lactate testing based on clinical 
markers and/or discharge diagnosis codes. We defined a broad subgroup of patients with 
suspected infection as any patient with a blood culture order (regardless of culture results) 
during hospitalization. We defined severe sepsis using the methods of Angus et al as 
modified by Iwashyna et al [19, 20]. This widely cited claims definition uses 1286 codes for 
infection and 13 codes for acute organ dysfunction; if a code from both categories is present, 
or an explicit code for severe sepsis (995.92) or septic shock (785.52) is present, the patient 
is labeled as having severe sepsis. In order to enable us to estimate the timing of suspected 
sepsis, we focused on the subset of patients who had at least one blood culture order with 
concurrent parenteral antibiotics started within ± 1 day of the blood culture, with any 
antibiotics continued for at least 3 days (or until death or hospital discharge if this occurred 
prior to 3 days). Finally, we defined suspected septic shock as a blood culture order and both 
vasopressors (norepinephrine, epinephrine, dopamine, vasopressin, and phenylephrine) and 
at least 3 days of antibiotics started within ±1 day of blood culture order. We applied this 
denominator without regards to discharge diagnoses given that administrative coding for 
sepsis is of variable accuracy and possibly changing over time [20–22]. Even though some 
of these patients likely ended up having non-infectious diagnoses, we reasoned that 
clinicians’ decisions to order blood cultures and at least 3 days of new antibiotics were 
strong indicators that they initially suspected a possible infection and therefore lactate 
measurement was also indicated for these patients.
2003–2013 Trends—We examined the annual proportion of hospitalizations that had a 
serum lactate level measured at any point during hospitalization amongst patients with 
suspected infection. To examine trends in serial lactate testing, we assessed the annual 
proportion of hospitalizations with suspected infection and lactates ≥ 4.0 mmol/L that had a 
repeat lactate checked within 6 and 24 hours, excluding patients that died within that time 
window. In hospitalizations where lactate testing was performed, we examined whether 
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clinical thresholds for measuring lactates might be changing over time by examining the 
annual proportion of patients that required vasopressors before or at the time of lactate 
measurement. In order to estimate how well clinicians are doing at ordering lactates at the 
time of suspected sepsis in patients with severe sepsis, we examined annual rates of lactate 
measurement within ± one day of the first blood culture order concurrent with antibiotic 
initiation. We also examined lactate measurements within ± 1 day of the first blood culture 
with concurrent antibiotics and vasopressors in patients with suspected septic shock.
Lactate Testing in Patients with Severe Sepsis in 2013—We examined factors that 
might be associated with the decision to measure a lactate at the time of suspected sepsis, 
defined as within ± one day of first blood culture order with antibiotics, in patients with 
severe sepsis. We focused on patients hospitalized in 2013 in order to assess most current 
practices. The following variables were considered: age (continuous variable), sex, race 
(white vs nonwhite), Elixhauser summary comorbidity score (continuous variable), 
mechanical ventilation at time of suspected sepsis, ICU care or vasopressor before or at time 
of suspected sepsis, and laboratory values indicative of organ dysfunction on the day of 
blood culture order (or the closest day if no lab drawn that day): creatinine ≥ 2.0 mg/dL, 
total bilirubin ≥ 2.0 mg/dL, international normalized ratio (INR) >1.5, and platelet count 
<100,000/μL. We also included other key labs that might influence suspicion of infection or 
hypoperfusion: anion gap >16 mEq/L, ≥5 % immature neutrophils (bands) on white blood 
cell count (WBC) differential, maximum white blood cell count >12,000/μL or minimum 
WBC <4,000/μL, positive blood cultures before or at the time of suspected sepsis, 
hematocrit <21%; and albumin <2.5 g/dL. Lastly, we included hospital-onset sepsis, 
admission to a nonmedical service, and which hospital the patient was admitted to (with 
MGH as the reference hospital). We defined hospital-onset sepsis as the first blood culture 
order associated with initiation of parenteral antibiotics occurring on or after the 3rd 
calendar day of admission, with day of admission being day 1. The primary service was 
designated by the specialty of the attending of record at hospital discharge.
Statistical Analyses
Eleven-year trends were fitted using linear regression. All trends were analyzed in each 
hospital separately and in aggregate. In the cohort of severe sepsis patients hospitalized in 
2013, we compared differences in the above variables in patients who had lactates measured 
at the time of suspected sepsis versus those who did not have lactates measured. We used the 
Wilcoxon rank sum test for continuous variables and the chi-squared statistic for categorical 
variables. Variables that were statistically significant were included as potential predictors 
for failure to measure lactates at time of suspected sepsis in the multivariate model. For all 
analyses, we considered p < 0.05 to be statistically significant and used two-tail tests. The c-
statistics was calculated to assess the discriminatory capability of the final multivariate 
model. All analyses were performed using SAS version 9.3 (SAS Institute, Cary, NC).
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RESULTS
There were 230,620 patients admitted from 2003–2013 who had blood cultures during their 
hospitalization. Clinical characteristics of these patients and the subgroups of severe sepsis 
and suspected septic shock are shown in Table 1.
Trends in Serum Lactate Testing
Lactate Measurements During Hospitalization and At Time of Suspected 
Sepsis—In 2003, 2,024 out of 19,221 patients with suspected infection (11%) had serum 
lactates measured during their hospitalization, compared to 10,153 out of 21,090 patients 
(48%) in 2013 (p<0.001 for linear trend over 11 years) (Figure 1). The trend was similar for 
the other subgroups. In 2003, 495 out of 2,677 (19%) patients with severe sepsis had a 
lactate measured within ± one day of first blood culture with concurrent antibiotics, 
compared to 3,313 out of 5,071 patients (65%) in 2013 (p<0.001 for linear trend). For 
suspected septic shock, patients with orders for blood cultures with concurrent antibiotics 
and vasopressors had lactates measured within ± one day of blood culture order in 542 of 
1,225 cases (31%) in 2003, compared to 2,022 of 2,708 cases (75%) in 2013 (p<0.001 for 
linear trend).
Serial Lactate Testing—In 2003, patients with suspected infection and a lactate level 
≥4.0 mmol/L had a repeat lactate measured within 6 hours in 86 out of 367 cases (23%) and 
within 24 hours in 202 out of 340 cases (59%). In 2013, 951 out of 1,387 cases (69%) had a 
repeat lactate measured within 6 hours and 1,218 out of 1,291 cases (94%) had a repeat 
lactate measured within 24 hours (p<0.001 for linear trend for both comparisons) (Figure 2).
Clinical Threshold for Measuring Lactates—In patients with suspected infection, 998 
out of 2,024 cases (49%) received vasopressors prior to or on the day of lactate 
measurement in 2003, compared to 2,139 of 10,153 cases (21%) in 2013 (p<0.001 for linear 
trend) (Figure 3).
All of the above trends were identical when examined in each hospital individually with 
p<0.001.
Lactate Testing in 2013 in Patients with Severe Sepsis
Of the 5,071 patients with severe sepsis in 2013, 1,758 (35%) did not have a lactate 
measured at the time of suspected sepsis, and 1,288 (25%) did not have a lactate measured at 
any point during hospitalization. On bivariate analysis, patients who did not have a lactate 
measured at time of suspected sepsis were more likely to be younger, have a lower burden of 
comorbidities, not require vasopressors or mechanical ventilation or ICU care, have hospital 
onset sepsis, be admitted to a nonmedical service, and have fewer signs of organ dysfunction 
or infection compared to those who did have lactates measured (Table 2). Median hospital 
length of stay was longer in the no-lactate group (14 days vs 11 days, p<0.001), though the 
hospital mortality rate was lower (10% vs 17%, p<0.001).
On multivariate analysis (Table 3), risk factors for failure to measure a lactate at the time of 
suspected sepsis included hospital-onset of sepsis vs community-onset (adjusted odds ratio 
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7.56, 95% CI 6.31–9.06, p<0.001), and admission to a nonmedical service (adjusted odds 
ratio 2.08, 95% CI 1.76–2.46, p<0.001). Factors significantly associated with lactate 
measurement after adjustment included concurrent or preceding vasopressors, ICU care, 
older age, higher Elixhauser comorbidity score, positive blood cultures before or at time of 
suspected sepsis, anion gap >16 mEq/L, ≥5 % bands, total bilirubin ≥ 2.0 mg/dL, and WBC 
> 12,000/μL or <4,000/L. The c-statistic for the multivariate model was 0.816.
DISCUSSION
We found that the use of serum lactate testing in patients with suspected or diagnosed sepsis 
increased steadily every year since 2003. Rates of lactate measurement in patients who had 
blood cultures drawn during hospitalization increased more than 4-fold in our study. In 
2003, lactates were measured only a fraction of the time in patients with severe sepsis or 
those with evidence of suspected septic shock, but was performed in the majority of cases by 
2013. The increase in lactate testing also included higher rates of serial lactate 
measurements in patients with elevated lactate levels, as almost all these patients had a 
repeat measurement within 24 hours. In addition, lactates were increasingly measured in 
patients who were not on vasopressors, suggesting that clinicians have lowered their 
thresholds for obtaining lactate levels by extending testing to patients without overt 
hypotension.
The marked increase in the use of lactate testing at our hospitals likely reflects multiple 
factors. There have been a plethora of publications over the past two decades documenting 
the prognostic utility of lactate [6, 7, 23–25], its use as a therapeutic target for resuscitation 
[8, 9], its ability to alter provider behavior [26], and the potential for rapid testing to improve 
patient outcomes [10]. Studies demonstrating the use of lactate as a severity marker in 
hemodynamically stable patients with suspected infection [7, 25] could also explain why 
clinicians are increasingly extending the test to patients who are not on vasopressors. In 
addition, the uptake of lactate testing we observed probably also reflects the increasing 
success and penetration of the Surviving Sepsis Campaign, which has increasingly 
emphasized the importance of spot and serial lactate testing, to clinicians and hospitals 
around world [11]. Other hospitals have also noted improvements in lactate testing rates 
over time associated with sepsis quality initiatives [13, 14, 27]. Our findings shed additional 
light on this important topic insofar as neither of our hospitals was explicitly enrolled in the 
Surviving Sepsis Campaign, and therefore provide a window into the diffuse of lactate 
testing beyond the Campaign.
Although rates of lactate testing have increased significantly over time, our analysis of 
practice patterns in 2013 suggests that there is still significant room for improvement. The 
vast majority of patients who had lactate levels ≥ 4.0 mmol/L had a repeat level measured 
within 24 hours, but almost one third did not have a level rechecked within 6 hours. This 
suggests that the use of lactate clearance as a resuscitation target [8, 9] and the SSC 
recommendations of serial lactate testing for patients with hyperlactatemia have not become 
fully ingrained in clinicians yet. In addition, analysis of patients with severe sepsis in 2013 
showed that more than one third did not have lactates measured around the time of suspected 
sepsis, and a quarter did not have lactates measured at any point during hospitalization. 
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Closer examination of these patients showed a lower degree of organ dysfunction and 
proportion of patients in the ICU in the no-lactate group, indicating that clinicians are 
preferentially drawing lactates in more severely ill patients. However, the hospital length of 
stay and mortality rate in severe sepsis patients without lactates measured were high, 
suggesting that clinicians may underappreciate the utility of lactate testing to identify 
patients with occult hypoperfusion who are at increased risk for adverse outcomes. 
Interestingly, even overt hypotension is not always triggering lactate tests, as a quarter of 
patients in 2013 who required vasopressors and had concurrent blood culture orders and 
antibiotics never had a lactate measured at time of suspected infection.
We identified two clinical factors related to processes of care that predict failure to measure 
a lactate in patients with severe sepsis. For patients of roughly equivalent level of illness and 
organ dysfunction, a lactate was less likely to be measured if suspected sepsis occurred in 
the hospital rather than being present on admission, and if the patient was admitted to a 
nonmedical service. Other studies have shown that sepsis that occurs on hospital ward units 
is associated with worse outcomes, and that this may be due to delays in appropriate 
recognition and timely administration of fluids, vasoactive agents, and transfer to the ICU 
[13, 28]. Another recent study using a nationally representative administrative database 
showed risk-adjusted mortality was significantly worse for patients with a diagnosis of 
sepsis present-on-admission if they were directly admitted to the floor versus the emergency 
room [29]. Delayed recognition of severe illness in hospitalized patients versus those 
presenting to the emergency department has also been documented for other conditions [30]. 
All of this suggests that the current focus on lactate testing and early sepsis detection in 
emergency room settings should be extended to the inpatient setting as well. Targeting the 
implementation of automated triggers for lactate testing, sepsis protocols, and/or education 
initiatives to hospital ward units, particularly nonmedical units, might be a high yield area 
for quality improvement.
Our study has several limitations. First, our findings come only from two academic hospitals 
in one city. Hospitals around the world might vary significantly in the frequency of lactate 
testing, depending on resources and the presence or absence of specific protocols. In 
addition, both of our hospitals were participating sites for the ProCESS trial from 2008–
2013, which required that hospitals adhere to the Surviving Sepsis Campaign guidelines and 
use serum lactate levels to screen for hypoperfusion [31]. This may have influenced trends 
in lactate ordering over the latter part of the time period we studied and may therefore limit 
generalizability. Second, our estimate of the population of patients with possible sepsis may 
have been incomplete, as under-recognition of sepsis is common and misclassification is 
possible when using discharge diagnoses [20, 32, 33]. We chose the most widely used 
claims method, however, for retrospectively identifying patients with severe sepsis for 
purposes of quality monitoring. Furthermore, we addressed this limitation by considering 
three different methods to identify patients with suspected and diagnosed sepsis including 
two methods based solely on clinical data. Third, our assessment of risk factors for failure to 
measure a lactate level in patients with suspected sepsis was limited to data we could glean 
from electronic sources. Additional predictors such as vital signs, severity of illness scores, 
and evolving complications may also be important. Fourth, some degree of inaccuracy is 
possible when estimating the timing of suspected sepsis onset using the time stamps of 
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blood culture orders. Lastly, it is possible that some patients who did not have lactates 
measured might have been so overtly in shock and multiorgan failure that clinicians did not 
feel that lactates would add additional useful clinical information. However, the fact that 
overall level of illness was lower in the no-lactate group argues that this was not a major 
contributor.
In conclusion, the use of serum lactate testing in patients with suspected and diagnosed 
sepsis has increased dramatically since 2003, and clinicians appear to be progressively 
extending lactate testing to patients without overt signs of shock. However, even in 2013, 
serial lactate testing rates remained suboptimal, and a substantial proportion of patients with 
severe sepsis and those with clinical markers indicating suspected septic shock did not have 
serum lactate levels measured. Onset of suspected sepsis while hospitalized and admission 
to a nonmedical service were risk factors for failure to draw a lactate. Our findings have 
important implications for quality improvement and monitoring programs.
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Figure 1. 
Rising annual proportion of patients with suspected and diagnosed sepsis that had serum 
lactates measured during hospitalization or at time of suspected sepsis, 2003–2013.
Rhee et al. Page 11
Crit Care Med. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 2. 
Rising annual rates of repeat lactate measurements within 6 and 24 hours after documented 
lactate levels ≥ 4.0 mmol/L in patients with suspected infection, 2003–2013.
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Figure 3. 
Decreasing proportion of patients with suspected infection who required vasopressors before 
or on the day of first lactate measurement, 2003–2013.
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Table 1
Patient characteristics, 2003–2013.
Suspected Infectiona (n=230,620) Severe Sepsisb (n=41,275) Suspected Septic Shockc 
(n=24,330)
Median Age (IQR) 61 (47–73) 65 (53–76) 63 (51–74)
Male sex, n (%) 119,892 (52.0) 23,453 (56.8) 14,073 (57.8)
White race, n (%) 177,398 (76.9) 32,761 (79.4) 19,120 (78.6)
Comorbidities
 Cancer, n (%) 50,532 (21.9) 8,215 (19.9) 4,095 (16.8)
 Diabetes Mellitus, n (%) 42,484 (18.4) 6,229 (15.1) 3,081 (12.7)
 Heart Failure, n (%) 35,346 (15.3) 9,183 (22.3) 5,685 (23.4)
 Liver Disease, n (%) 13,667 (5.9) 2,682 (6.5) 1,446 (5.9)
 Lung Disease, n (%) 36,925 (16.0) 6,115 (14.8) 3,391 (13.9)
 Renal Disease, n (%) 27,829 (12.1) 588 (14.3) 2,694 (11.1)
 Median Elixhauser Score (IQR) 6 (0–12) 9 (5–14) 8 (4–13)
Positive blood cultures, n (%) 22,389 (9.7) 9,637 (23.4) 5,381 (22.1)
Nonmedical service, n (%) 77,269 (33.5) 11,563 (28.0) 10,748 (44.2)
Required ICU Care, n (%) 65,218 (28.3) 24,761 (60.0) 20,178 (82.9)
Median Hospital Length of Stay (IQR) 7 (4–13) 13 (7–24) 15 (8–26)
Hospital Mortality, n (%) 14,687 (6.4) 7,502 (18.2) 6,300 (25.9)
aSuspected Infection = patients with a blood culture order anytime during hospitalization.
bSevere Sepsis = patients with blood culture order with concurrent antibiotics and discharge diagnoses consistent with infection and organ 
dysfunction.
cSuspected septic shock = patients with blood culture order with concurrent antibiotics and vasopressors.
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Table 2
Clinical characteristics of patients with severe sepsis in 2013 who did and did not have serum lactates 
measured at time of suspected sepsis.
Lactate Measured (n=3,313) No Lactate Measured 
(n=1,758) p-value
a
Median Age (IQR) 67 (55–77) 65(54–76) 0.012*
Male sex, n (%) 1,913 (57.7) 1,015 (57.7) 0.997
White Race , n (%) 2,636 (79.6) 1,442 (82.0) 0.036*
Median Elixhauser Score (IQR) 9 (5–14) 8 (4–13) <0.001*
Vasopressor before or at time of suspected sepsis, n (%) 1,411 (42.6) 375 (21.3) <0.001*
Mechanical Ventilation at time of suspected sepsis, n (%) 921 (27.8) 264 (15.0) <0.001*
ICU Care before or at time of suspected sepsis, n (%) 2,171 (65.5) 589 (33.5) <0.001*
Positive Blood Cultures before or at time of suspected sepsis, n (%) 510 (15.4) 177 (10.1) <0.001*
Laboratory Derangements (at time of suspected sepsis)
 Albumin <2.5 g/dL, n (%) 567 (17.1) 179 (10.2) <0.001*
 Anion Gap >16 mEq/L, n (%) 678 (20.5) 80 (4.6) <0.001*
 Bands ≥ 5%, n (%) 617 (18.6) 140 (8.0) <0.001*
 Creatinine ≥ 2.0 mg/dL, n (%) 861 (26.0) 268 (15.2) <0.001*
 Hematocrit <21%, n (%) 390 (11.8) 175 (10.0) 0.050
 INR >1.5, n (%) 731 (22.1) 231 (13.1) <0.001*
 Platelets <100/μL, n (%) 905 (27.3) 494 (28.1) 0.553
 Total bilirubin ≥ 2.0 mg/dL, n (%) 414 (12.5) 112 (6.4) <0.001*
 WBC >12,000/μL, n (%) 1,724 (52.0) 624 (35.5) <0.001*
 WBC <4,000/μL, n (%) 556 (16.8) 356 (20.3) 0.002*
Hospital onset sepsis, n (%) 436 (13.2) 704 (40.1) <0.001*
Nonmedical Service, n (%) 781 (23.6) 613 (34.9) <0.001*
Hospital (BWH vs MGH), n (%) 1,252 (37.8) 754 (42.9) <0.001*
ap-values obtained by Wilcoxon rank sum test for continuous variables (age, Elixhauser score) and the chi-squared statistic for categorical 
variables (all other variables).
*
Indicates statistically significant variables.
Abbreviations: ICU = intensive care unit, INR = international normalized ratio, WBC = white blood cell count, BWH = Brigham and Women’s 
Hospital, MGH = Massachusetts General Hospital.
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Table 3
Multivariate analysis of risk factors for failure to measure serum lactates at time of suspected sepsis in patients 
with severe sepsis in 2013.
Adjusted Odds Ratio (95% CI) p-value
Age (years) 0.99 (0.99, 1.00) 0.009*
White Race 1.22 (1.03, 1.46) 0.026*
Elixhauser Comorbidity Score 0.99 (0.98, 1.00) 0.005*
Vasopressor before or at time of suspected sepsis 0.42 (0.34, 0.52) <0.001*
Mechanical Ventilation at time of suspected sepsis 0.98 (0.79, 1.23) 0.898
ICU Care before or at time of suspected sepsis 0.28 (0.23, 0.33) <0.001*
Positive Blood Cultures before or on day of suspected infection 0.68 (0.54, 0.84) <0.001*
Laboratory Derangements (at time of suspected sepsis)
 Albumin <2.5 g/dL 0.83 (0.66, 1.04) 0.104
 Anion Gap >16 mEq/L 0.32 (0.24, 0.42) <0.001*
 Bands ≥ 5% 0.52 (0.41, 0.66) <0.001*
 Creatinine ≥ 2.0 mg/dL 0.90 (0.74, 1.09) 0.270
 INR >1.5 0.86 (0.71, 1.05) 0.136
 Total bilirubin ≥ 2.0 mg/dL 0.60 (0.47, 0.79) <0.001*
 WBC >12,000/μL 0.62 (0.53, 0.72) <0.001*
 WBC <4,000/μL 0.69 (0.57, 0.84) <0.001*
Hospital Onset Sepsis 7.56 (6.31, 9.06) <0.001*
Nonmedical Service 2.08 (1.76, 2.46) <0.001*
Hospital (BWH vs MGH) 1.10 (0.95, 1.26) 0.201
*
Indicates statistically significant variables.
Abbreviations: ICU = intensive care unit, INR = international normalized ratio, WBC = white blood cell count, BWH = Brigham and Women’s 
Hospital, MGH = Massachusetts General Hospital.
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